Contact Us
Privacy Policy
E-paper
Advertise with us
Friday, May, 03,2024
Search
Home
India
State
Rajasthan
World
Sports
Entertainment
Live TV
Press releases
OP-ED
Click Here
Epaper
Click Here
IPL 2024
Click Here
Lok Sabha Elections
Login
Logout
iNCOVACC
Bharat Biotech's intranasal heterologous booster dose likely to hit market in February first week
India-made iNCOVACC, world's first intra-nasal vaccine to receive approval for both primary series, Heterologous booster